Close Menu

NEW YORK (GenomeWeb) – Bruker said today that its FluoroCycler XT PCR system and FluoroType MTBDR 2.0 Liquid Array assay for detecting tuberculosis and antibiotic resistance have received the CE-IVD mark.

According to Bruker, the PCR-based MTBDR test identifies pathogens directly from patient samples in three hours without the need for culturing. It can also detect more than 60 mutations in TB genes, which the company said can provide information on up to 522 patterns of antibiotic resistance, helping to guide therapy.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.